Newport Beach, CA. BioQuest Corp. (OTC: BQST), a leader in innovative technologies, is excited to announce that it has reached final terms of an agreement to acquire BotMakers, Inc., a cutting-edge provider of AI-driven voice agents and chatbot solutions. The agreement solidifies BioQuest’s commitment to expanding its footprint in the rapidly growing AI industry and accelerates the company’s ability to deliver transformative technology solutions.

BotMakers, Inc. specializes in the development of advanced conversational AI systems for businesses, enabling them to streamline customer interactions, increase efficiency, and enhance service offerings. With this acquisition, BioQuest will integrate BotMakers’ AI expertise into its operations, creating a dynamic synergy that will drive growth and open new market opportunities.

“We are thrilled to have officially reached an agreement on the acquisition of BotMakers, Inc.,” said Tom Hemingway CEO of BioQuest Corp. “This acquisition positions BioQuest at the forefront of AI innovation, allowing us to offer a broader range of services and solutions to our clients. BotMakers’ technology and expertise will play a pivotal role in our growth strategy, and we look forward to working together to shape the future of AI-powered customer engagement.”

Under the finalized terms of the agreement, BotMakers, Inc. will operate as a division of BioQuest Corp., continuing to serve its current clients while expanding its AI capabilities under the BioQuest brand. The acquisition enables BioQuest to provide enhanced AI solutions across multiple industries, including telecommunications, retail, healthcare, and finance.

BotMakers AI technologies will complement BioQuest’s existing offerings, with plans to further develop and integrate these solutions into BioQuest’s product suite. This strategic acquisition is expected to drive BioQuest’s long-term growth and increase market share in the competitive AI landscape.

“We believe this acquisition will greatly benefit both companies,” said Sella Hall, CEO of BotMakers, Inc. “Combining BotMakers’ AI solutions with BioQuest’s technological infrastructure and market reach will accelerate our ability to deliver cutting-edge AI-driven products to a wider audience. We’re excited for what the future holds as we join forces with BioQuest.”

The completion of this acquisition comes as BioQuest prepares for a public offering through a Reg A fundraising effort to raise $5 million for growth, marketing, product development, and expansion. With the combined expertise and resources of both companies, BioQuest is poised for continued success and leadership in AI innovation.

For more information about BioQuest Corp. and the acquisition of BotMakers, Inc., please visit bioquestcopr.com or contact:

About BioQuest Corp.

BioQuest Corp. (OTC: BQST) is an innovative technology company focused on the development of cutting-edge solutions across various industries. With a mission to revolutionize the way businesses operate through advanced technologies, BioQuest is committed to delivering top-tier products and services that meet the evolving needs of its customers. The company is actively expanding its portfolio to include AI-driven solutions, positioning itself as a leader in the future of technology.

About BotMakers, Inc.

BotMakers, Inc. is a leading developer of conversational AI technologies designed to help businesses automate customer interactions and improve operational efficiency. Specializing in AI voice agents and chatbots, BotMakers offers comprehensive solutions for a wide range of industries. Its focus on innovation and customer service has earned the company a reputation as a forward-thinking player in the AI space.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations, estimates, projections, and assumptions made by management. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” and similar expressions are intended to identify such forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements. Such risks and uncertainties include, but are not limited to, the ability to successfully integrate the acquisition, execute the growth strategy, raise the necessary funds through the planned Reg A offering, and the general economic conditions affecting the AI industry.

BioQuest Corp. undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. For additional information on the risks and uncertainties that could affect BioQuest Corp.’s future results, please review the company’s filings with the Securities and Exchange Commission (SEC), including its Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K.